However, up to now, the use of pharmacological agents able to decrease TAM infiltration in the tumor stroma such as the colony stimulating factor 1 receptor inhibitor PLX3397 have not shown the expected results [23]. The gene discussed is CSF1R; the disease is neoplasm.